Dow Up 0.11% Nasdaq Up 0.50%

Celgene Corporation (CELG)

-NasdaqGS
95.02 Up 0.32(0.34%) Aug 29, 4:00PM EDT
|After Hours : 95.07 Up 0.05 (0.05%) Aug 29, 7:43PM EDT
Prev Close:94.70
Open:95.28
Bid:94.91 x 900
Ask:95.29 x 100
1y Target Est:100.03
Beta:1.1
Next Earnings Date:23-Oct-14CELG Earnings announcement
Day's Range:94.26 - 95.29
52wk Range:66.85 - 96.15
Volume:2,784,988
Avg Vol (3m):4,510,720
Market Cap:75.97B
P/E (ttm):30.24
EPS (ttm):3.14
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
CELGUp 0.34%75.97B
JNJUp 0.76%292.55B

Key Statistics

Forward P/E (1 yr):19.43
P/S (ttm):10.77
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :3.67
Quarterly EPS Est (Sep-14) :0.95
Mean Recommendation*:1.8
PEG Ratio (5 yr expected):0.98

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Celgene Corporation, a biopharmaceutical company, discovers, develops, and commercializes therapies to treat cancer and immune-inflammatory related diseases in the United States and internationally. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback